Balyasny Asset Management LLC Agenus Inc Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $31,790 - $64,558	-24,454 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $57,466 - $84,855	24,454 New	24,454 $60,000
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $84,793 - $129,056	-53,329 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.26 - $4.65 $82,017 - $168,753	36,291 Added 213.0%	53,329 $121,000
Q1 2018 May 15, 2018	SELL	$3.51 - $6.04 $41,151 - $70,812	-11,724 Reduced 40.76%	17,038 $80,000
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.78 $1.78 Million - $2.61 Million	-546,134 Reduced 95.0%	28,762 $94,000
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $2 Million - $2.55 Million	574,896	574,896 $2.54 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.